CONMED Corporation (NYSE:CNMD) Stock Has Consensus Target Price of $44.00

Posted by Geri Gentry on Nov 8th, 2026

CONMED Corporation (NYSE:CNMD – Get Free Report) has been assigned a consensus rating of “Reduce” from the eight brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $44.00.

A number of equities research analysts recently commented on CNMD shares. Needham & Company LLC reiterated a “hold” rating on shares of CONMED in a report on Monday, July 13th. Zacks Research upgraded shares of CONMED from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Wall Street Zen raised shares of CONMED from a “hold” rating to a “buy” rating in a research note on Monday, July 20th. Wells Fargo & Company upped their price objective on shares of CONMED from $46.00 to $49.00 and gave the company an “equal weight” rating in a research note on Thursday, October 29th. Finally, JPMorgan Chase & Co. increased their target price on shares of CONMED from $45.00 to $50.00 and gave the stock a “neutral” rating in a report on Thursday, October 29th.

Read Our Latest Analysis on CNMD

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CNMD. Signaturefd LLC grew its position in shares of CONMED by 82.7% in the 3rd quarter. Signaturefd LLC now owns 548 shares of the company’s stock worth $25,000 after buying an additional 248 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of CONMED during the second quarter valued at approximately $27,000. Versant Capital Management Inc raised its holdings in shares of CONMED by 210.8% during the second quarter. Versant Capital Management Inc now owns 1,125 shares of the company’s stock valued at $37,000 after acquiring an additional 763 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in shares of CONMED during the second quarter valued at approximately $41,000. Finally, Rockefeller Capital Management L.P. raised its holdings in shares of CONMED by 48.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,043 shares of the company’s stock valued at $42,000 after acquiring an additional 341 shares in the last quarter.

CONMED Price Performance

CNMD opened at $51.44 on Tuesday. The stock’s 50 day simple moving average is $47.00 and its 200 day simple moving average is $41.67. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.49 and a quick ratio of 0.70. CONMED has a 1 year low of $31.44 and a 1 year high of $54.80. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of 21.26, a PEG ratio of 2.39 and a beta of 0.90.

CONMED (NYSE:CNMD – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $335.56 million for the quarter, compared to analysts’ expectations of $336.28 million. CONMED had a return on equity of 13.93% and a net margin of 5.36%. The business’s quarterly revenue was down .7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.08 EPS. As a group, analysts predict that CONMED will post 4.58 earnings per share for the current year.

About CONMED

(Get Free Report)

CONMED Corporation is a medical technology company that develops, manufactures, and sells surgical devices and related equipment. Its products are used by hospitals, ambulatory surgery centers, and other healthcare providers in orthopedic and general surgery procedures.

The company’s orthopedic portfolio includes arthroscopy systems, powered surgical instruments, sports medicine products, tissue ablation systems, implants, and related accessories. Its general surgery offerings include electrosurgical equipment, insufflation systems, smoke evacuation products, surgical visualization technologies, and devices used in minimally invasive procedures.

Founded in 1970, CONMED serves healthcare customers through direct sales and distribution channels in the United States and international markets.